Clinical Trials
5 trialsNCT03295227 2026-01-30
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT03023319 2022-06-14
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Augusta University
Phase 1 Completed
NCT00066404 2020-05-13
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00921739 2020-04-02
ESIMRT
Duke University
Phase 1 Completed
NCT00314873 2014-06-03
Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma
Indiana University
Phase 1 Completed